C09979705 / invoice 10000

Reason: GeorgiaAppointment Notes: DOCP and lytesIntern: GLDRAFTHistory:Murray is presented today for a DOCP injection (hypoadrenocorticism diagnosed in July 2023). He receives daily prednisolone and DOCP dosing every 35 days. Electrolytes were last reassessed on 19/11/25. He also has intermittent dermatological signs (superficial pyoderma, dull sparse hair coat, epidermal collarettes), which resolve via a combination of topical Malaseb washes +/- oral cephalexin. At his last visit (28/01/25), OR that Murray had been well at home. His skin improved with weekly malaseb baths and ongoing bacticorten use. Today, OR going well, skin is being managed well with bacticorten and malaseb,.EDDU normal. Current Medications:Prednisolone 1.5mg PO SIDExamination Findings:T: DNT               MM: pink, moist P: 124 bpm          CRT: <2s R: Panting Demeanour: BARHydration: Euhydrated Weight: 46.5kg (+300g)BCS: 7/9 MCS: normal muscle mass Cardiovascular: WNL Respiratory: WNL Abdomen: WNL Peripheral LNs: WNL Ocular: WNL Ears: WNL Integument:- good hair regrowth in regions of previous epidermal collarettes on left proximal trunkOral exam: WNL Musculoskeletal: WNL Gait: WNL Neurological: Full exam deferred, normal mentation Rectal: NPAssessment:Problem List:- Hypoadrenocorticism (controlled)- Dermal lesions/ superficial pyoderma - improvedMurray remains clinically well with apparent control of his hypoadrenocorticism. No changes will be instituted to dosing of prednisolone at this stage. His electrolyte levels were last reassessed in November - he will be due for a radiometer at his next DOCP dosage. Ongoing weekly malaseb baths are recommended, given Murray's favourable response to increased frequency of topical therapy for management of his dermatological signs. Treatment:DOCP (Zycortal) 1.5mL (25mg/mL) SQ (~0.8mg/kg)Plan:DOCP and radiometer recheck next visit (5 weeks' time).    Vital Signs